As the glucose lowering effect of FGF19 could be separated from body weight change, our findings are reminiscent of the improved glycemic control observed in patients after gastric bypass surgery, which displayed improved insulin secretion and reduced insulin resistance, independently of weight loss [39,40]. The gene discussed is INS; the disease is Insulin resistance.